Robyn Puro;
Prabir Chakraborty;
John Richards;
Ronald Hiebsch;
Michael Donio;
W Casey Wilson;
Benjamin Capoccia;
Carrie Brachmann;
Vicki Sung;
Arun Kashyap;
Daniel Pereira
215 AO-176, a highly differentiated clinical stage anti-CD47 antibody, preferentially binds tumor versus normal cell CD47 when complexed to β1 integrin
You can manage bookmarks using lists, please log in to your user account for this.
Media type:
E-Article
Title:
215 AO-176, a highly differentiated clinical stage anti-CD47 antibody, preferentially binds tumor versus normal cell CD47 when complexed to β1 integrin
Contributor:
Robyn Puro;
Prabir Chakraborty;
John Richards;
Ronald Hiebsch;
Michael Donio;
W Casey Wilson;
Benjamin Capoccia;
Carrie Brachmann;
Vicki Sung;
Arun Kashyap;
Daniel Pereira
Published:
2020
Published in:
Journal for ImmunoTherapy of Cancer, 8 (2020)